TEAM
-
Thales Papagiannakopoulos
PH.D. PRINCIPAL INVESTIGATOR
> Associate Professor, Department of Pathology, NYU
> Postdoctoral Fellow with Tyler Jacks Lab, Koch Integrative Insitute for Cancer Research
> Ph.D. in Molecular and Cellular Biology, Kenneth Kosik Lab, UC Santa Barbara, 2010
> B.S. Molecular Genetics, University of Sussex, UK, 2004
Thales is an Assistant Professor and the Director of the Molecular Oncology and Tumor Immunology Graduate Program.
-
-
-
Sahith Rajalingam
RESEARCH ASSOCIATE
> M.S. In Pharmacology and Toxicology, Long Island University, 2019
> Pharm-D, Osmania University, Hyderabad, India, 2015
Sai is a research associate/lab manager, he joined the lab in September 2021. He ensures that the lab operates... Other things apart from his job, he likes to travel and cook.
-
Jozef Piotr Bossowski, Ph.D.
POSTDOCTORAL FELLOW
> Ph.D. in Biology at Université Côte d'Azur, Nice, France, 2014-2018
Jozef joined the Team in 2019 after completing his PhD in France. His work is focused on Integrated Stress Response in lung cancer and its impact on tumor microenvironment. Working on stress response allowed him to develop his own strategies to deal with stress and successfully apply his findings to his life/work balance. Always cheerful and happy to collaborate and discuss scientific ideas.
-
Makiko Hayashi, Ph.D.
POSTDOCTORAL FELLOW
> The Uehara Memorial Foundation Postdoctoral Fellowship (2ys)
> Ph.D. in Medical Science, Masayuki(Masi) Yamamoto Lab, Tohoku University, Japan, 2020
Makiko is a postdoctoral fellow who joined the lab in July 2020. Makiko studies how disruption of circadian-rhythms affects lung cancer progression. Outside of science, Makiko loves art, she loves to draw. Makiko’s dream is to draw the cover illustration of her publication in Nature?
-
Ray Pillai, M.D.
PULMONARY FELLOW (JOINT WITH KORALOV LAB)
> BSc in Pharmacology at University of British Columbia, 2008
> MD at University of Cincinnati, 2012
> Internal Medicine Residency at University of Southern California, 2015
Ray is a postdoctoral fellow and also a practicing physician. He joined the lab in 2017. Ray studies how common lung cancer mutations reprogram the immune microenvironment, promote immune evasion and resistance to immunotherapy.
